Nautilus Biotechnology (NAUT) Change in Cash (2020 - 2026)

Nautilus Biotechnology has reported Change in Cash for 7 years, with the latest figure at -$1.5 million in Q2 2026.

• Quarterly Change in Cash fell 219.77% year-over-year to -$1.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$21.3 million (down 322.43% YoY) and the FY2025 annual result came in at -$15.3 million, down 284.97% from the prior year.
• Change in Cash slipped to -$1.5 million in Q2 2026 per NAUT's latest filing, from $2.2 million in the prior quarter.
• Over five years, Change in Cash peaked at $23.2 million in Q4 2024 and troughed at -$74.3 million in Q4 2022.
• A 5-year average of -$9.6 million and a median of -$1.2 million in 2024 frame the typical range for Change in Cash.
• The sharpest annual moves came in 2024 and 2025: Change in Cash slumped 1613.38% in 2024, then jumped 244.43% in 2025.
• Over 5 years, Change in Cash stood at -$74.3 million in 2022, then advanced by 26.37% to -$54.7 million in 2023, then soared by 142.48% to $23.2 million in 2024, then plunged by 149.43% to -$11.5 million in 2025, then surged by 87.29% to -$1.5 million in 2026.
• According to Business Quant data, Change in Cash over the past three periods registered -$1.5 million, $2.2 million, and -$11.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.